Around the Net

P&G Faces Harsh Questions On Acquisition Of Merck

Hoping to talk up a flashy new $4.2 billion health acquisition, Procter & Gamble CEO David Taylor instead faced harsh questions from Wall Street analysts on a Thursday conference call over the Tide maker's sputtering performance. P&G modestly beat profit and sales forecasts with a $2.5 billion profit on $16.3 billion of sales during the third quarter ended March 30. But the company's results were riddled with deteriorating numbers.

Read the whole story at Cincinnati Enquirer »

Next story loading loading..